Submit Manuscript    >>    Login | Register

Meet the Expert Doctor

Enter your question here:

Browse Questions Answered by Our Experts (OR)
 <<  <  ... 106 107 108 109 110
Answer:
This question is vague. If I understand your question correctly, I suspect you want to know the cardiovascular side effects of AF. AF is a rhythm disorder with a panacea of cardiovascular side effects. In addition to the significant symptoms and life style limitations it causes, there are definitive long term implications. Rapid uncontrolled heart rates due to rapidly conducting impulses to the lower chambers (ventricles) can cause tachycardia induced cardiomyopathy (weakening of heart muscle causing heart failure), if not controlled timely can result in permanent damage and scar tissue formation in the heart muscle. The cardiac chambers can get dilated and blood pooling in the left upper chambers can result in clot formation in the left atrial appendage. These clots can get loose and cause stroke and affect other organs of the body they travel to. The continued scarring and chamber dilation is a negative predictor of success rates for rhythm control with either medications or ablation
Answer:
Similar to percutaneous catheter ablation, atrial tissue remodeling continues for at least 8 weeks after procedure. In catheter ablation patients, the first 8 weeks is considered as the blinding phase where the recurrences typically do not have significant impact on the long term outcomes. Any AF after that is definitely considered as a recurrence. Three to six months is considered typically the healing phase. Although, there is a great likelihood that recurrence after three months is typically suggestive of failure to rhythm control with or without an antiarrhythmic drug. In the immediate aftermath of the MAZE surgery majority of the patients will be treated with an antiarrhythmic drug upto six months and as needed cardioversions to restore and maintain sinus rhythm until the atrial reverse remodeling is complete. However, there is no extensive definitive data on this subject. If you are not on any rhythm drugs I suggest you should be considered for one and attempt a cardioversion.
Answer:
Dear Ms. Johnson! Normally, the electrical activity of the heart spontaneously starts from the region of the heart’s electrical system called Sinus node which is sort of a built in internal pacemaker. This normally fires from 60-100 beats per minute. When your heart goes into atrial fibrillation the upper chambers can beat ineffectively up to 400-600 beat per minute. This rapid rhythm will automatically suppress the sinus node. When the atrial fibrillation terminates, the sinus node which has been suppressed takes a few seconds to recover. This slight delay in recovery to resume the heart’s electrical activity is what is termed as post conversion pause. Factors that will suggest if these conversion pauses are pathologic are not – age, was there any evidence of sinus node problems in the absence of AF, antiarrhythmic medication type and dose, and the severity of symptoms. A small percentage of elderly patients have underlying sinus node dysfunction along with AF – which is termed as tachybrady syndrome in medical terms. These patients exhibit severe slowing of heart rates along with rapid heart rates when they are in atrial fibrillation. The medications like beta blockers, calcium channel blockers, digoxin and antiarrhythmic drugs (flecainide, propaphenone, sotalol, amiodarone and dofetalide etc) can make their heart rates much slower exacerbating symptoms. There is strong evidence that once the AF is addressed the sinus node function seems to improve significantly. A study from Michel Haissaguerre’s group has clearly demonstrated this phenomenon in their paper in Circulation in 2003. I suggest you should probably think of AF ablation if your physician considers you to be an appropriate candidate. If you continue to have severe symptomatic pauses despite excellent rhythm control then you will need a pacemaker at that point.
Answer:
Yes, in some families AF is hereditary. This is still work in progress. Atrial fibrillation is traditionally regarded as a sporadic, nongenetic disorder. However, recent growing evidence points to an important heritable basis for atrial fibrillation, with significant genetic determinants. The role of genetics in atrial fibrillation pathogenesis and familial susceptibility has been studied by various studies. A recent analysis by Darbar and colleagues of 2610 patients seen in an arrhythmia clinic during an 18-month period revealed that at least 5% of atrial fibrillation patients and 15% with lone atrial fibrillation have a positive family history. Detailed epidemiological data from the Framingham Heart Study demonstrated that parental atrial fibrillation significantly increases the future risk for offspring . This study found that atrial fibrillation in at least one parent increased the risk of atrial fibrillation among 2243 offspring participants by about 85% after adjustment for known atrial fibrillation risk factors with even stronger results when age was limited to younger than 75 in both parents and offspring. In a population-based cohort study by Arnar and colleagues of over 5000 atrial fibrillation patients in Iceland, first-degree relatives of atrial fibrillation patients were 1.77-fold more likely to have atrial fibrillation than in the general population.
Answer:
I have been involved in AF ablation since my fellowship days. I trained at the Cleveland Clinic with Dr. Andrea Natale who ran one of the busiest AF labs in the world. I had the good fortune of being part of over 250 AF ablations during my fellowship years and I did about 300 cases in two years since my fellowship, at the University of Kansas Hospitals starting 2006. This is should give you a fair idea of what my experience levels are.
Answer:
Pulmonary vein stenosis is the narrowing of the pulmonary veins. This can happen occasionally in patients after AF ablation. If the narrowing is severe > 70% and affects two veins on the same side they can impede blood return from the lung on that side of the chest. This can result in symptoms of shortness of breath, fatigue, coughing, blood in sputum. PV stenosis used to be a frequent problem during the early years of AF ablation when the radiofrequency lesions were placed either deep inside the vein or just at the opening of the vein. As the electrophysiology community realized this problem, the ablation points moved away from the opening of the vein. The current strategies involve doing circular lesions farther away from the opening either in the funnel portion (antral) of the vein are in the atrial body. The closer the lesion set is to the opening better is the confidence in the isolation of the veins. The farther we move away from the opening of the vein the more difficult it gets to completely isolate the vein. The current rates of PV stenosis range from 2-5% depending on the technique. CT or MRI of the heart are done to monitor for the PV diameters before and after the AF ablation. Any degree of stenosis should be followed by repeat CT or MRI scans to assess for progression of the stenosis. Ventilation/perfusion scans help to assess the physiologic impact of the stenosis on the lung perfusion. Pulmonary vein angioplasty and stenting are helpful in mitigating symptoms in patients with significant stenosis.
No.of Questions Asked: 1135
No.of Questions Answered: 1096

Biosense Webster
event date
Disclaimer

1. JAFIB and the invited expert reserve the right to decline any question. The question declined will not appear in the list of questions asked.

2. The questions or advice from the expert can not be considered as alternatives to your clinician's advice. This discussion is only for educational/informational use. Your EP doctor is THE person to advice you on treatment and management of your condition.

Feedback : Your suggestion on this new initiative are much appreciated. Please write to the managing editor(editor@jafib.com) about your feedback on "Meet the Expert".

Ablation Specialist

View Ablation Specialists